Data on Home Prices and the FDA’s Decision on a Cholesterol-Lowering Drug by THE NEW YORK TIMES

By THE NEW YORK TIMES

This week, the Food and Drug Administration is expected to approve Repatha; several important pieces of housing market data will be released; and shareholders in Mylan are scheduled to vote on a matter related to a takeover bid.

Published: August 24, 2015 at 12:00AM

from NYT Business Day http://ift.tt/1MNgV2X

from WordPress http://ift.tt/1KeVh5O
via Hadi Aboukhater